Rabta IV Injection 1's

Rabta IV Injection 1's is used to treat gastric/duodenal ulcers, gastro-oesophageal reflux disease (GERD), heartburn, prevention of acid-aspiration, stress-induced mucosal injury, and Zollinger-Ellison syndrome.

Rabta IV Injection 1's contains 'Rabeprazole' that works by blocking the action of the enzyme known as gastric proton pump, which is responsible for the production of acid. This helps in reducing the amount of acid produced, heals the ulcers and prevents the formation of new ulcers.

In some cases, you may experience certain common side effects, such as pain at the site of injection, diarrhoea, dizziness, dry mouth, headache, and abdominal pain. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.

On long-term treatment, Rabta IV Injection 1's may cause low magnesium levels and vitamin B12 levels and increase the risk of bone fractures. Consult your doctor if you are pregnant or breastfeeding. Rabta IV Injection 1's may cause dizziness, so drive only if you are alert. Rabta IV Injection 1's is not recommended for children as safety has not been established. Avoid consuming alcohol along with Rabta IV Injection 1's as it could lead to increased drowsiness and can elevate the production of stomach acid.

Rabta IV Injection 1's is used in the treatment of Gastro-oesophageal reflux disease (GERD), Duodenal/Gastric ulcers, and Zollinger-Ellison syndrome. The detailed uses of Rabta IV Injection 1's are as follows:

• Treatment of Gastro-oesophageal Reflux Disease (GERD): Rabta IV Injection 1's helps to manage symptoms of GERD, such as heartburn and acid reflux, by reducing stomach acid production.
• Relief from Duodenal/Gastric Ulcers: Rabta IV Injection 1's helps to treat duodenal and gastric ulcers by reducing stomach acid, allowing the ulcers to heal.
• Management of Zollinger-Ellison Syndrome: Rabta IV Injection 1's manages excessive acid production in the stomach, helping to alleviate symptoms and prevent complications associated with the condition.

• Follow your doctor’s instructions on the dosage and timing of this medication to ensure safe and effective use.
• Rabta IV Injection 1's will be administered by the doctor or healthcare professional.
• Do not self-administer.

Rabta IV Injection 1's belongs to a group of antiulcer medicines called proton pump inhibitors. Rabta IV Injection 1's is used to treat gastric ulcers, duodenal ulcers, gastro-oesophageal reflux disease (GERD), heartburn, prevention of acid-aspiration, stress-induced mucosal injury, and Zollinger-Ellison syndrome. Rabta IV Injection 1's works by blocking the action of the enzyme known as gastric proton pump, which is responsible for the production of acid. This helps in reducing the amount of acid produced, heals the ulcers and prevents the formation of new ulcers.

Do not take Rabta IV Injection 1's if you are allergic to any of its contents. Inform your doctor if you have a stomach tumour, liver disease, or if you are due to have Chromogranin A blood test. On long-term treatment, Rabta IV Injection 1's may cause low magnesium levels, vitamin B12 levels, and increase the risk of bone fractures; the doctor may advise regular tests for monitoring your condition. Consult your doctor before starting Rabta IV Injection 1's if you are pregnant or breastfeeding. Rabta IV Injection 1's may cause dizziness, so drive only if you are alert. Rabta IV Injection 1's is not recommended for children as safety has not been established. Avoid consuming alcohol along with Rabta IV Injection 1's as it could lead to increased drowsiness and can elevate the production of stomach acid. Keep your doctor informed about your health condition and medicines to rule out any side-effects.